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LiesegangTeam 
Bone to bone marker 
Falling for bone and cartilage metabolism – Professor Dr Annette Liesegang discusses the 
possibilities of measurements in animals and animal models 
There is a strong relationship between formation and resorption of bone as well as in cartilage in 
humans and in animals. Bone turnover and cartilage turnover can be monitored non-invasively by 
using biochemical bone markers or cartilage markers, which are enzymes and other protein products 
released by osteoblasts/chondroblasts and osteoclasts/chrondroclasts respectively. 
Biochemical markers 
The biochemical markers of bone formation currently in use include bone isoenzyme of alkaline 
phosphatase, osteocalcin and propeptides derived from terminal ends of the type I procollagen 
molecule. The most useful markers of bone resorption are breakdown products of type I collagen. 
The longest established method is the measurement of hydroxyproline (HYP) in urine, which is not 
specific for bone, because it can be found in all collagen types and is also derived from the diet. The 
measurement of collagen crosslinks, deoxypyridinoline (DPD) and pyridinoline (PYD) is comparatively 
more specific to monitor bone resorption. DPD and PYD are of use in human medicine in the 
diagnosis and evaluation of bone diseases and in the prediction of the occurrence of fractures and 
the rates of bone loss. The carboxyterminal telopeptide of type I collagen (ICTP), which has been 
used in several animal species, is also a promising bone marker. 
There are other degradation products of type I collagen of the organic bone matrix such as serum 
CrossLaps (CTX), which is a marker of bone resorption. Biochemical markers for cartilage degradation 
(CTX-II, C2C, C1,2C and COMP) and cartilage synthesis (CPII, CS846 and YKL-40) have also been used 
in many studies. 
Growth diagnosis 
These may be new possibilities for diagnosis of growth retardment or growth disorders (extent of 
joint destruction), prediction of disease progression (in humans) and rapid assessment of the efficacy 
of therapy (humans). For both tissues, the ratio of bone (or cartilage) resorption markers and 
formation markers is used to objectify the remodelling of these tissues. These markers have been 
extensively investigated by the team at the Institute of Animal Nutrition, where the courses of 
different bone markers in different species, especially during gestation and lactation, were studied in 
comparison to human medicine. Various influences on the interactions between bone resorption and 
formation were also studied there. 
The basic research of Professor Dr Annette Liesegang was focused on the importance of physiological 
and nutritional influences on bone resorption and formation. The institute is expert in many species 
(ruminant, dog, reptile, pig, chicken), especially those to be used as models for human medicine. 
Recently, the work is also focused on calcium absorption in the intestines, where 
immunohistochemical methods as well as western blot have been developed. In this area until now, 
several research projects were and are published. The same is true for the action of Vitamin D under 
UVB radiation or as supplement in nutrition. 
Diagnostic imaging 
Another possibility to monitor bone metabolism is the use of diagnostic imaging in humans and 
animals. Bone strength has been shown to depend on the amount and density of bone present. On 
the basis of this relationship, several techniques have been developed to measure the bone mineral 
density (BMD) and the bone mineral content (BMC) non-invasively at different skeletal sites. 
Peripheral quantitative computed tomography (pQCT) has become an established method for 
evaluating the skeletal status, assessing osteoporosis, determining fracture risk and monitoring 
metabolic diseases and therapies in humans. 
In veterinary medicine, the application of pQCT technology is still rare, although this methodology 
has the potential to be an important research and clinical tool for, for example, the study of 
endocrine and metabolic diseases that affect the calcium-phosphorus balance, orthopaedic diseases 
and fracture risks. 
At the Institute of Animal Nutrition, the Liesegang team is mainly dealing with problems related to 
bone and cartilage physiology and the impact of nutrition in this field. Many studies have been 
realised where the focus was put on bone metabolism in the context of osteoporosis. Mainly sheep 
and goats were used as animal models, but pigs are also of high interest in this context as well as rats 
or mice. The Institute of Animal Nutrition also has facilities and infrastructure to conduct animal 
experiments. Animal stables are available as well as a laboratory. Animals will be taken from the 
institute’s own sheep and goat herd, which are managed with veterinary care. 
Future avenues 
It is important to study the regulatory mechanism on a systemic as well as on a cellular level. 
Furthermore, elucidating the systemic effects and controlling the development of bone mineral 
content and density, plus the course of selected bone markers, are opening up future avenues to 
treating patients more effectively through therapeutic interventions based on modern approaches 
with biotechnology. 
Parathyroid hormone (PTH) secreted from the parathyroidea plays an important role on mineral 
metabolism and bone remodelling. Under physiological circumstances, 1.25(OH)2-Vitamin D plays a 
minor role in the influence on bone but increases the absorption of calcium and phosphorus, which 
are essential for the mineralisation of bone. Other important hormones are the growth hormone and 
the insulin-like growth factors (IGFs), which influence the epiphyses and are the predominant factors 
for a normal skeletal development. All these hormones are intensively studied under different special 
focuses at the Institute of Animal Nutrition. 
A number of studies have described the measurement of biochemical markers of bone cell activity in 
humans, sheep, horses, pigs, cattle, dogs, chickens and birds and have shown dynamic changes in 
bone cell function associated with skeletal maturation, exercise, ovariectomy, osteomyelitis and the 
effects of hormones and drugs on the skeleton. In general, the measurement of markers of bone cell 
activity remains exclusively a method used in scientific research in animals, although there is an 
increasing amount of work being undertaken worldwide on their potential clinical applications in 
companion animals, particularly in dogs and horses. 
Within the surrounding CABMM, many possibilities are given since the Institute of Animal Nutrition is 
able to use the whole infrastructure as well as parts within this infrastructure and deliver their 
expertise and laboratory skills to the other partners. These sophisticated tools are available to all 
institutions which need this expertise within their projects and with this give their work and ours 
more impact. 
 
Fig. 1 Bone resorption marker (ICTP) in two different groups of pigs over six weeks. The time pattern 
shows a diet-induced bone resorption. * = significant differences 
 
Fig. 2 Peripheral quantitative computer tomography – to measure bone mineral density and content 
in living animals over a longer period of time. A – Diaphysis, B – Metaphysis, White = mineralised 
bone 
 
Fig. 3 Bone density as well as cortical thickness (white ring very thin, blue surrounding is muscle) 
decrease, while bone resorption increases at the beginning of lactation in small ruminants. Already 
some days after parturition, the bone seems to ‘recover’ and bone density as well as the cortical 
thickness increase again (white cortical bone is thicker again). Pink = goats’ milk, blue = sheep’s milk 
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